(Q46483699)

English

Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone

scientific article published in June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

endometrial hyperplasia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Anne Beate Vereide

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

Turid Kaino

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

Georg Sager

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

Anne Ørbo

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

Scottish Gynaecological Clinical Trials Group

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

Gynecologic Oncology

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

97

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

740-750

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Apoptosis may be an early event of progestin therapy for endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Apoptosis and apoptosis-related proteins in human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Immunohistochemical assay for oestrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

BCL-2 family: regulators of cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Apoptosis, bcl-2 expression, and proliferative activity in human endometrial stroma and endometrial granulated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.030

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.02.030

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15885761

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46483699&oldid=2113438378"